These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7502878)

  • 1. Oral immunization against mucosal candidiasis in a mouse model.
    Rahman D; Challacombe SJ
    Adv Exp Med Biol; 1995; 371B():1663-6. PubMed ID: 7502878
    [No Abstract]   [Full Text] [Related]  

  • 2. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole and parotid saliva IgA and IgA-subclass responses to Candida albicans in HIV infection.
    Sweet SP; Challacombe SJ; Naglik JR
    Adv Exp Med Biol; 1995; 371B():1031-4. PubMed ID: 7502746
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis.
    Drobacheff C; Millon L; Monod M; Piarroux R; Robinet E; Laurent R; Meillet D
    Clin Chem Lab Med; 2001 Jun; 39(6):519-26. PubMed ID: 11506465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization against the oral indigenous bacteria of the BALB/c mouse.
    Marcotte H; Rodrigue L; Gamache M; Lavoie MC
    Adv Exp Med Biol; 1995; 371B():1173-6. PubMed ID: 7502778
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma beads loaded with Candida albicans cytosolic proteins impart protection against the fungal infection in BALB/c mice.
    Ahmad E; Fatima MT; Saleemuddin M; Owais M
    Vaccine; 2012 Nov; 30(48):6851-8. PubMed ID: 23044405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
    Li Wq; Hu Xc; Zhang X; Ge Y; Zhao S; Hu Y; Ashman RB
    Vaccine; 2011 Jul; 29(33):5526-33. PubMed ID: 21645574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell-independent selection of memory T cells after mucosal immunization with Candida albicans.
    Jones-Carson J; Vazquez-Torres FA; Balish E
    J Immunol; 1997 May; 158(9):4328-35. PubMed ID: 9126995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with the Candida albicans membrane fraction and in combination with fluconazole protects against systemic fungal infections.
    Mizutani S; Endo M; Ino-Ue T; Kurasawa M; Uno Y; Saito H; Kato I; Takesako K
    Antimicrob Agents Chemother; 2000 Feb; 44(2):243-7. PubMed ID: 10639344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral immunization of mice against candidiasis.
    Jensen J; Warner T; Johnson C; Balish E
    J Infect Dis; 1996 Jul; 174(1):133-40. PubMed ID: 8655983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of Candida albicans mannan on development of protective immune responses in experimental murine candidiasis.
    Garner RE; Domer JE
    Infect Immun; 1994 Feb; 62(2):738-41. PubMed ID: 7507901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escheriosome mediated cytosolic delivery of Candida albicans cytosolic proteins induces enhanced cytotoxic T lymphocyte response and protective immunity.
    Chauhan A; Swaleha Z; Ahmad N; Farazuddin M; Vasco A; Abida M; Mohammad O
    Vaccine; 2011 Jul; 29(33):5424-33. PubMed ID: 21645572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A therapeutic vaccine for mucosal candidiasis.
    Elahi S; Clancy R; Pang G
    Vaccine; 2001 Mar; 19(17-19):2516-21. PubMed ID: 11257386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of mice from lethal endogenous Candida albicans infection by immunization with Candida membrane antigen.
    Tansho S; Ab S; Mizutani S; Ono Y; Takesako K; Yamaguchi H
    Microbiol Immunol; 2002; 46(5):307-11. PubMed ID: 12139389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization protocols for use in animal models of candidiasis.
    Segal E; Sandovsky-Losica H
    Methods Mol Biol; 2009; 499():27-34. PubMed ID: 19152036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis.
    Elahi S; Pang G; Clancy R; Ashman RB
    Infect Immun; 2000 Oct; 68(10):5771-7. PubMed ID: 10992484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing Antifungal Vaccines in an Animal Model of Invasive Candidiasis and in Human Mucosal Candidiasis.
    Segal E
    Methods Mol Biol; 2017; 1625():343-353. PubMed ID: 28585001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis.
    De Bernardis F; Lucciarini R; Boccanera M; Amantini C; Arancia S; Morrone S; Mosca M; Cassone A; Santoni G
    Infect Immun; 2006 Jul; 74(7):4282-94. PubMed ID: 16790803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis.
    Han Y; Rhew KY
    Arch Pharm Res; 2012 Nov; 35(11):2021-7. PubMed ID: 23212645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis.
    Han Y; Ulrich MA; Cutler JE
    J Infect Dis; 1999 Jun; 179(6):1477-84. PubMed ID: 10228070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.